Oxford University has since stated the trial will continue after the death of the volunteer, adding an independent review had revealed no safety concerns. The Federal University of Sao Paulo, which is coordinating phase 3 trials in Brazil, said an independent review committee had also recommended the trial continue. 'All significant medical events are carefully assessed by trial investigators, an independent safety monitoring committee and the regulatory authorities. Trials resumed after British regulators and an independent review concluded the illness was not a side effect of the vaccine. In June, Brazil's government announced a deal with Oxford University and AstraZeneca to purchase 100 million doses of its potential Covid-19 vaccine.

Source: Daily Mail October 21, 2020 18:04 UTC